Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.62+0.02 (+0.19%)
Close on Nov 18, 2026Market cap $893.06MP/E 13.8Yield –
Bioventus net income
Net income is the profit left for shareholders after every expense, interest and tax.
Bioventus's net income for the twelve months ending Jun 27, 2026 was $54.46M. For fiscal 2025 it was $22.73M. The highest annual figure on record is $22.73M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.73M | – |
| FY2024 | Dec 31, 2024 | -$36.13M | – |
| FY2023 | Dec 31, 2023 | -$156.23M | – |
| FY2022 | Dec 31, 2022 | -$158.70M | -919.1% |
| FY2021 | Dec 31, 2021 | $19.38M | +18.1% |
| FY2020 | Dec 31, 2020 | $16.41M | +139.5% |
| FY2019 | Dec 31, 2019 | $6.85M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 27, 2026 | $33.44M | +348.3% |
| Q1 FY2026 | Mar 28, 2026 | $3.11M | – |
| Q4 FY2025 | Dec 31, 2025 | $14.76M | – |
| Q3 FY2025 | Sep 27, 2025 | $3.16M | – |
| Q2 FY2025 | Jun 28, 2025 | $7.46M | – |
| Q1 FY2025 | Mar 29, 2025 | -$2.64M | – |
| Q4 FY2024 | Dec 31, 2024 | -$388.00K | – |
| Q3 FY2024 | Sep 28, 2024 | -$5.17M | – |
| Q2 FY2024 | Jun 29, 2024 | -$25.68M | – |
| Q1 FY2024 | Mar 30, 2024 | -$4.89M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.10M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.30M | – |
| Q2 FY2023 | Jul 1, 2023 | -$3.68M | – |
| Q1 FY2023 | Apr 1, 2023 | -$139.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$31.93M | – |
| Q3 FY2022 | Oct 1, 2022 | -$108.25M | – |
| Q2 FY2022 | Jul 2, 2022 | -$7.25M | – |
| Q1 FY2022 | Apr 2, 2022 | -$11.28M | -145.2% |
| Q4 FY2021 | Dec 31, 2021 | -$364.00K | -113.1% |
| Q3 FY2021 | Oct 2, 2021 | -$1.07M | -112.7% |
| Q2 FY2021 | Jul 3, 2021 | -$4.13M | – |
| Q1 FY2021 | Apr 3, 2021 | $24.94M | +127.9% |
| Q4 FY2020 | Dec 31, 2020 | $2.78M | – |
| Q3 FY2020 | Sep 26, 2020 | $8.46M | – |
| Q2 FY2020 | Jun 27, 2020 | -$5.77M | – |
| Q1 FY2020 | Mar 28, 2020 | $10.94M | – |
See a number that looks wrong?